In this month's American Family Physician, there is a good article on Counseling Issues in Tubal Sterilization.
It's more than just a discussion of tubal ligation. There's a good table which lists some of the pros and cons of many contraceptive options – including newer options like Nuvaring and Evra.
I wonder if the pharmaceutical companies are choosing the names of their medications based on whether the domain names remain available …
